News
Here’s a round-up of recent events, plus some top stories from previous years.
GC Aesthetics announces new Head of Medical Affairs
GC Aesthetics is pleased to announce the appointment of Dr. Chris Brotherston as “GCA Head of Medical Affairs”. This newly created position brings together our technical, regulatory, and clinical functions across the organisation to support the effective and efficient...
Truth Creative provides global branding support to GC Aesthetics
Truth Creative has provided strategic branding and business support to global premium breast implant provider GC Aesthetics, launching a series of innovative new products and a revolutionary augmented reality app allowing patients to see how they will look after...
GC Aesthetics announces new Head of Supply Chain
GC Aesthetics is pleased to announce the appointment of Monique Marcellin as the new GCA Head of Supply Chain. In this extended role Monique will continue to align supply and demand and will lead supply chain initiatives dedicated to customer satisfaction and GCA...
GC Aesthetics introduces the GCA Comfort Plus Warranty – the new lifetime warranty
GC Aesthetics Ltd, one of the world’s leading producers of silicone implants has announced a brand new lifetime warranty on all GC Aesthetics’ breast implants1. Warranty applies to all GCA silicone gel breast implants implanted by an appropriately qualified...
COVID-19 – Information for our Global Community
Dear partners, The health and wellbeing of our staff, customers and partners is a priority for all of us at GC Aesthetics. We recognise that this is an exceptional time of uncertainty and rapid change for everyone in our global community. Within GC Aesthetics our...
GC Aesthetics supports the International Society of Aesthetic Plastic Surgery as Gold Sponsor
Dublin, Ireland – 4 September 2019 – GC Aesthetics (GCA), a global medical technology company with over 40 years of experience, is pleased to announce that it has become a Gold Sponsor of the International Society of Aesthetic Plastic Surgery (ISAPS). GCA is committed...
BIA-ALCL GC Aesthetics Communication update
The Australian Therapeutic Good Administration (TGA) has released a public statement of the preliminary outcomes from its review of textured implants on July 11, 2019. The notice proposes certain actions the TGA may take in relation to textured implants used in...
GC Aesthetics to Launch Two New Products in Brazil and Europe
Dublin, Ireland – June 20, 2019 – GC Aesthetics, Inc. (GCA), a privately-held medical technology company providing aesthetic solutions for global healthcare markets, announced today that the Company will be launching two new products. The first product, Eve 4.0, will...
10 Year Data Shows Long-Term Safety and Efficacy of GC Aesthetics Implants
GC Aesthetics (GCA) announced today that data from a European clinical study of over 500 women implanted with the GC Aesthetics’ Eurosilicone breast implants was published online on the April 27, 2019 in Aesthetic Surgery Journal Open Forum. The study, titled...
A Note from GC Aesthetics To Address BIA-ALCL Concerns
Following recent concerns that have been raised about a possible connection between textured breast implants and the rare condition known as anaplastic large cell lymphoma (BIA-ALCL), the French government agency responsible for medicines and health products (ANSM)...
GC Aesthetics Announces Progress in U.S. Regulatory Strategy and Key Hires to Support Growth
GC Aesthetics (“GCA”), a medical technology company providing healthcare aesthetic solutions for global healthcare markets, announced today several recent positive developments for the Company, demonstrating continued progress on its U.S. and international growth...
GC Aesthetics Raises $97 Million in Financing
GC Aesthetics (“GCA”), a medical technology company providing aesthetic solutions for global healthcare markets, announced today that the company has raised $97 million of new capital. The financing comprises a combination of debt, provided by Hayfin Capital...